Related Experiment Video
Updated: May 12, 2026

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
Published on: August 18, 2015
Monocytes in neonatal stroke and hypoxic-ischemic encephalopathy: Pathophysiological mechanisms and therapeutic
1Carlos Chagas Filho Biophysics Institute Federal University of Rio de Janeiro Rio de Janeiro Brazil.
Insights
Neonatal stroke and hypoxic-ischemic encephalopathy involve immune cell infiltration into the brain. Understanding monocyte roles in these conditions is crucial for developing new infant neurological treatments.
Area of Science:
- Neuroscience
- Immunology
- Neonatal Medicine
Background:
- Neonatal arterial ischemic stroke (NAIS) and neonatal hypoxic-ischemic encephalopathy (HIE) are significant causes of infant neurological deficits with limited treatments.
- These conditions trigger innate immune responses, recruiting peripheral immune cells like monocytes to the brain.
- The dual role of monocytes/monocyte-derived cells in neuroinflammation and brain repair in NAIS and HIE is not fully understood.
Purpose of the Study:
- To comprehensively review monocyte infiltration mechanisms and functions in the ischemic brain, specifically in NAIS and HIE.
- To explore the potential long-term consequences of persistent monocyte-derived macrophages in the neonatal brain.
- To discuss therapeutic strategies targeting monocytes and their potential for cell-based therapies.
Main Methods:
- Literature review focusing on monocyte infiltration and function in neonatal stroke and HIE.
- Analysis of current evidence regarding immune cell recruitment and persistence in the neonatal brain.
- Synthesis of information on therapeutic approaches and cell-based therapy potential.
Main Results:
- Monocyte infiltration is a key feature of the innate immune response in NAIS and HIE.
- Monocytes and derived macrophages may play complex roles in both damaging neuroinflammation and beneficial brain repair.
- Evidence suggests monocyte-derived macrophages can persist long-term in the brain post-insult, with unknown consequences.
Conclusions:
- Further research is needed to elucidate the precise roles of monocytes in neonatal ischemic brain injury.
- Targeting monocyte pathways presents a potential therapeutic avenue for NAIS and HIE.
- Monocyte-based cell therapies warrant investigation for treating neonatal neurological impairments.
Abstract:
Neonatal arterial ischemic stroke (NAIS) and neonatal hypoxic-ischemic encephalopathy (HIE) are common causes of neurological impairments in infants, for which treatment options are very limited. NAIS and HIE induce an innate immune response that involves the recruitment of peripheral immune cells, including monocytes, into the brain. Monocytes and monocyte-derived cells have the potential to contribute to both harmful and beneficial pathophysiological processes, such as neuroinflammation and brain repair, but their roles in NAIS and HIE remain poorly understood. Furthermore, recent evidence indicates that monocyte-derived macrophages can persist in the brain for several months following NAIS and HIE in mice, with possible long-lasting consequences that are still unknown. This review provides a comprehensive overview of the mechanisms of monocyte infiltration and their potential functions in the ischemic brain, focusing on HIE and NAIS. Therapeutic strategies targeting monocytes and the possibility of using monocytes for cell-based therapies are also discussed.
More Related Videos
Related Concept Videos
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke ll: Pathophysiology
Cerebral Edema ll: Pathophysiology

